Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MF-268 shows long-lasting antiamnesic efficacy in rats

June 12, 1998

Japanese companies team up to develop compounds for schizophrenia

June 12, 1998

Mechanism of neuroprotective effect of selegiline; efficacy in HIV-associated dementia

June 11, 1998

SSRIs versus tricyclics as regards risk of hip fracture in the elderly

June 11, 1998

Astra stops development of local anesthetic

June 11, 1998

Neuroprotective agents based on enzyme inhibition prepared at P&U

June 11, 1998

Pfizer team reveals heterobicyclic CRF antagonists

June 11, 1998

AHP reports dopamine autoreceptor agonists with antipsychotic potential

June 10, 1998

Anesta signs Actiq partnership with Lafon

June 10, 1998

Perimidine-based CRF antagonists developed at Agouron

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...